PROMETHEUSBİLGİ ŞEHRİParşömen atölyesine gir →

GÜNÜN PARŞÖMENİ · 11 EYLÜL 2026 · NÖROBİLİM VE HÜCRE BİYOLOJİSİ

Tau proteini beynin enerji sistemlerini nasıl bozabilir?

How Tau May Disrupt the Brain’s Energy Systems

C1 · 4 dakikalık okuma · Kaynak: NIH Research Matters, 8 Eylül 2026

Metin

Tau normally supports communication between nerve cells, but abnormal forms of the protein accumulate in disorders such as Alzheimer’s disease. An NIH-funded team investigated how these altered proteins affect mitochondria, the structures that generate cellular energy. Experiments involving flies, mice, human brain tissue and cultured nerve cells showed that phosphorylated tau entered mitochondria and activated reverse electron transport, a process capable of damaging cells. The process then increased tau phosphorylation, producing a harmful feedback loop. When researchers used a compound to interrupt reverse electron transport, motor and memory problems declined in animal models, while cultured human nerve cells became more resistant to stress. The findings identify a possible treatment target rather than an established therapy. The compound has not yet reached clinical trials, so further research is needed to determine whether blocking this pathway can safely benefit people with tau-related diseases.

Özet ve soru Prometheus’a aittir. Haberin tamamı: NIH Research Matters ↗

Beş ifade

  • accumulate: birikmek
  • cellular energy: hücresel enerji
  • feedback loop: geri besleme döngüsü
  • interrupt a process: bir süreci kesintiye uğratmak
  • treatment target: tedavi hedefi

YDS mini sorusu

According to the passage, why should the findings not yet be regarded as proof of an effective human treatment?

  1. The researchers observed no improvement in memory or movement in the animal models.
  2. The proposed pathway appears only in cultured cells and not in living organisms.
  3. The compound still requires clinical testing to establish its safety and benefit in people.
  4. The experiments failed to connect abnormal tau with changes inside the mitochondria.
  5. The study focused on healthy tau rather than the phosphorylated form linked to disease.
Cevabı ve açıklamasını göster

Doğru cevap: C

Parça, sonuçların umut verici bir tedavi hedefi gösterdiğini; ancak bileşiğin henüz klinik deneylere ulaşmadığını ve insanlarda güvenli ve yararlı olup olmadığının bilinmediğini vurguluyor.

The compound has not yet reached clinical trials, so further research is needed to determine whether blocking this pathway can safely benefit people with tau-related diseases.

Öbür parşömenler

Bütün parşömenler → · Bugünün parşömenlerini atölyede çöz →